Department of Pharmacy Practice, ISF College of Pharmacy , Moga , India.
Department of Pharmacy, Government Pharmacy Institute , Patna , India.
Expert Rev Pharmacoecon Outcomes Res. 2019 Oct;19(5):575-580. doi: 10.1080/14737167.2019.1580574. Epub 2019 Feb 20.
: Objectives of this study were to assess risk factors, cost of treatment, and therapy outcomes in stroke patients. : This cross-sectional study was conducted in 130 patients of either sex at a government tertiary care hospital of India. Relevant information was collected from available records and through patient interview after permission from the ethics committee. National Institute of Health Stroke Score (NIHSS) was used to assess therapy outcome. Analysis of variance and the students t-test were applied appropriately where needed. : Higher body mass index, sedentary lifestyle, tobacco use, and elevated systolic blood pressure were observed as risk factors in participants. The mean cost of stroke treatment observed at this hospital was Indian Rupee 17,934.71 (€ 218.70; USD 267.67). The direct medical cost was the principal component in stroke treatment that ranged from 6% to 27% of the average six-month salary of patients in different socioeconomic classes. A significant improvement ( < 0.05) in health outcome (NIHSS Score) was observed in participants after treatment. : The data on the cost of stroke treatment from this study may be used for further pharmacoeconomic studies.
本研究旨在评估中风患者的风险因素、治疗费用和治疗效果。本横断面研究在印度一家政府三级护理医院的 130 名患者中进行。从现有记录中收集相关信息，并在伦理委员会批准后通过患者访谈获得。采用国立卫生研究院中风评分（NIHSS）评估治疗效果。需要时应用方差分析和学生 t 检验。参与者中观察到较高的体重指数、久坐不动的生活方式、吸烟和血压升高是风险因素。这家医院中风治疗的平均费用为 17934.71 印度卢比（218.70 欧元；267.67 美元）。直接医疗费用是中风治疗的主要组成部分，在不同社会经济阶层的患者中占平均六个月工资的 6%至 27%。治疗后，参与者的健康状况（NIHSS 评分）显著改善（<0.05）。本研究中关于中风治疗费用的数据可用于进一步的药物经济学研究。
